Merck Insider Moves: Maraldo’s Strategic Share Sales & RSU Accumulation Reflect Confidence in Oncology Growth
Merck insiders rebalancing shares—David Maraldo’s recent 401(k) filing shows a steady stake amid oncology wins and AI‑driven growth.
5 minutes to read